DE60030173T2 - Neue Indikationen für Mannan-binding Lectin (MBL) zur Behandlung von immungeschwächten Patienten - Google Patents

Neue Indikationen für Mannan-binding Lectin (MBL) zur Behandlung von immungeschwächten Patienten

Info

Publication number
DE60030173T2
DE60030173T2 DE60030173T DE60030173T DE60030173T2 DE 60030173 T2 DE60030173 T2 DE 60030173T2 DE 60030173 T DE60030173 T DE 60030173T DE 60030173 T DE60030173 T DE 60030173T DE 60030173 T2 DE60030173 T2 DE 60030173T2
Authority
DE
Germany
Prior art keywords
mbl
use according
subunit
mannan
oligomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60030173T
Other languages
English (en)
Other versions
DE60030173D1 (de
Inventor
Jens Christian Jensenius
Steffen Thiel
Original Assignee
Jens Christian Jensenius
Steffen Thiel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK66899 priority Critical
Priority to DKPA199900668 priority
Priority to DK150899 priority
Priority to DKPA199901508 priority
Application filed by Jens Christian Jensenius, Steffen Thiel filed Critical Jens Christian Jensenius
Publication of DE60030173D1 publication Critical patent/DE60030173D1/de
Application granted granted Critical
Publication of DE60030173T2 publication Critical patent/DE60030173T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links